Development of an Integrated Computational Pipeline for PARP‐1 Inhibitor Screening Using Hybrid Virtual Screening and Molecular Dynamics Simulations
Abstract Despite the promising anticancer properties of PARP‐1 inhibitors, their clinical use is hindered by side effects. It is crucial to explore new structural variants of these inhibitors to increase efficacy and minimize side effects, enhancing their clinical viability and therapeutic scope. In...
Saved in:
| Main Authors: | Guan Wang, Jingjing Guo, Feng Xu, Mingjuan Ji |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley-VCH
2025-08-01
|
| Series: | ChemistryOpen |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/open.202500021 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the radiochemistry of PARP inhibitors: a new era in therapy and imaging
by: Gianluca Destro, et al.
Published: (2025-07-01) -
Computational investigation of natural compounds as inhibitors against macrolide-resistant protein using virtual screening, molecular docking and MD simulations
by: Abdullah R. Alanzi, et al.
Published: (2025-05-01) -
PARP9-PARP13-PARP14 axis tunes colorectal cancer response to radiotherapy
by: Rimvile Prokarenkaite, et al.
Published: (2025-07-01) -
PARP9 and PARP14 are involved in microglia-mediated neuroinflammation in Alzheimer′s disease
by: HUANG Lian, WEI Hui
Published: (2025-05-01) -
Hybrid virtual screening and molecular dynamics approach for identification of allosteric modulator of EAAT2
by: Chennu Manisha, et al.
Published: (2024-10-01)